文献速递乳腺癌

致癌miRNA在乳腺癌中的作用及其治疗重要性

The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
PubMed 文献 · Eur J Cancer · 2016-12-18

本文综述了在乳腺癌发生、进展、侵袭和转移中具有致癌作用的miRNA,包括研究较多的miRNA簇和家族以及较少研究和新发现的致癌miRNA,并讨论了鉴定导致当前抗癌药物耐药或敏感的miRNA可能改善治疗选择和患者反应。

要点

  • 致癌miRNA失调可抑制控制凋亡、细胞周期、生长和增殖的关键通路。
  • 致癌miRNA在乳腺癌发生和进展、侵袭、转移中起重要作用。
  • 鉴定导致抗癌药物耐药或敏感的miRNA可能改善治疗选择。

核心结论

  • 致癌miRNA是乳腺癌的关键组分,可能为癌症治疗提供新途径。

研究设计与样本

  • 综述总结了文献中已知和新发现的在乳腺癌发生及进展、侵袭、转移中具有致癌作用的miRNA。

主要发现

  • 致癌miRNA失调导致抑制控制凋亡、细胞周期进展、生长和增殖的关键通路,从而使促癌因子上调驱动细胞生存、生长和增殖。
  • 本文讨论了乳腺癌中研究最多的致癌miRNA,包括涉及的簇和家族,以及较少研究和最近发现的致癌miRNA。
  • 这些miRNA为了解其过表达影响的调控元件的复杂性及对乳腺癌进展的整体影响提供了有价值的信息。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the discovery of tumour suppressive miRNA in 2002, the dysregulation of miRNAs was implicated in many cancers, exhibiting both tumour suppressive and oncogenic roles. Dysregulation of miRNAs was found to be involved in the initiation of oncogenesis, as well as the progression, invasion and metastasis of cancers. While normal miRNA inhibitory functions help regulate gene expression in the cell, oncogenic miRNA, when dysregulated can lead to suppression of critical pathways that control apoptosis, cell cycle progression, growth and proliferation. This suppression allows for the upregulation of pro-oncogenic factors that drive cell survival, growth and proliferation. Due to emerging discoveries, oncogenic miRNAs are proving to be a critical component in cancers, such as breast cancer, and may provide novel avenues for cancer treatment. In this article, we discuss the roles of the most studied oncogenic miRNAs in breast cancer including clusters and families involved as well as the less studied and recently discovered oncogenic miRNAs. These miRNAs provide valuable information into the complexity of regulatory elements affected by their overexpression and the overall impact in the progression of breast cancer. Also, identifying miRNAs causing or leading to resistance or sensitivity to current anti-cancer drugs prior to treatment may lead to an improvement in treatment selection and overall patient response. This review summarizes known and recently discovered miRNAs in literature found to have oncogenic roles in breast cancer initiation and the progression, invasion and metastasis of the disease.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. O'Bryan S, Dong S, Mathis JM, et al. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer. Eur J Cancer. 2016. PMID: 27997852. doi:10.1016/j.ejca.2016.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。